These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39042261)

  • 1. Huaier inhibits cholangiocarcinoma cells through the twist1/FBP1/Wnt/β-catenin axis.
    Cong L; Shi J; Zhao J; Li K; Dai D; Zhang B; Zhao W
    Mol Biol Rep; 2024 Jul; 51(1):842. PubMed ID: 39042261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
    Zhao W; Yang S; Chen J; Zhao J; Dong J
    Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma.
    Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J
    Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
    Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.
    Huang GL; Luo Q; Rui G; Zhang W; Zhang QY; Chen QX; Shen DY
    Mol Cell Biol; 2013 Sep; 33(17):3416-25. PubMed ID: 23798555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
    Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
    J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
    Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
    Shen DY; Zhang W; Zeng X; Liu CQ
    Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acids suppress metastatic features of human cholangiocarcinoma cells by suppressing twist.
    Lin CR; Chu TM; Luo A; Huang SJ; Chou HY; Lu MW; Wu JL
    J Nutr Biochem; 2019 Dec; 74():108245. PubMed ID: 31678746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway.
    Cheng H; Li Q
    BMC Gastroenterol; 2023 Aug; 23(1):279. PubMed ID: 37568083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42.
    Wang X; Zhang X; Sun J; Sun Y; Zhang Y; He L; Wang P; Li F; Sun C
    Toxicol Appl Pharmacol; 2023 May; 467():116492. PubMed ID: 36977438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
    Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
    Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA6 promotes epithelial-mesenchymal transition and metastasis through MUC1/β-catenin pathway in cholangiocarcinoma.
    Deng X; Jiang P; Chen J; Li J; Li D; He Y; Jiang Y; Zhang Y; Xu S; Li X; Wang S; Tian F
    Cell Death Dis; 2020 Oct; 11(10):860. PubMed ID: 33060563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.
    Huang GL; Zhang W; Ren HY; Shen XY; Chen QX; Shen DY
    Cancer Sci; 2015 Nov; 106(11):1515-23. PubMed ID: 26310932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
    Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
    J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-186 Suppresses the Progression of Cholangiocarcinoma Cells Through Inhibition of Twist1.
    Zhang M; Shi B; Zhang K
    Oncol Res; 2019 Sep; 27(9):1061-1068. PubMed ID: 31072421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs.
    Sanchon-Sanchez P; Briz O; Macias RIR; Abad M; Sanchez-Martin A; Marin JJG; Lozano E
    Biomed Pharmacother; 2023 Dec; 168():115658. PubMed ID: 37832404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic antitumor effect of Huaier combined with 5-Florouracil in human cholangiocarcinoma cells.
    Fu Z; Ma K; Dong B; Zhao C; Che C; Dong C; Zhang R; Wang H; Wang X; Liang R
    BMC Complement Altern Med; 2019 Aug; 19(1):203. PubMed ID: 31391034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.